Choosing appropriate patients for anticoagulation

Jan 29, 2017 by in NEUROLOGY Comments Off on Choosing appropriate patients for anticoagulation

Figure 5.1 Axial diffusion-weighted (right) and apparent diffusion coefficient (left) images show evidence of restricted diffusion in the right MCA distribution consistent with an acute cerebral infarction. Discussion Prosthetic heart…

read more

Stroke

Jan 28, 2017 by in NEUROLOGY Comments Off on Stroke

  I ACUTE (<24 HOURS) MIDDLE CEREBRAL ARTERY INFARCT, COMPUTED TOMOGRAPHY   KEY FACTS     Cerebral strokes are third most common cause of death in the United States; mortality with each…

read more

Neck Masses

Jan 28, 2017 by in NEUROLOGY Comments Off on Neck Masses

  NASOPHARYNGEAL MASSES   KEY FACTS     Most common tumors: squamous cell carcinoma (>80%), adenocarcinoma, minor salivary gland tumors, and lymphoma.     It is not clear if tobacco and alcohol use…

read more

Intra-Axial Tumors

Jan 28, 2017 by in NEUROLOGY Comments Off on Intra-Axial Tumors

  ASTROCYTOMA, LOW GRADE   KEY FACTS     Account for 10% to 30% of cerebral gliomas in adults.     Histologically, low-grade astrocytomas are fibrillary (diffuse), and over 80% eventually degenerate to…

read more

Infections and Inflammations

Jan 28, 2017 by in NEUROLOGY Comments Off on Infections and Inflammations

  MENINGITIS (UNCOMPLICATED)   KEY FACTS     Common causative organisms include Escherichia coli (E. coli) and streptococcus group B (newborns), Hemophilus (H. influenzae) (children <7 years), Neisseria (N. meningitides) (older children…

read more

Orbits

Jan 28, 2017 by in NEUROLOGY Comments Off on Orbits

  PERSISTENT HYPERPLASTIC PRIMARY VITREOUS   KEY FACTS    Refers to a persistent, hyperplastic, embryonic hyaloid vascular system; patients may also have seizures, hearing loss, mental deficiencies, and cataracts.    Persistent…

read more

Tumors and Tumorlike Conditions

Jan 28, 2017 by in NEUROLOGY Comments Off on Tumors and Tumorlike Conditions

  VERTEBRAL METASTASES   KEY FACTS    Vertebral métastases occur in 5% to 10% of all cancer patients, especially those with primary tumors in the breast, prostate, uterus, and lung; myeloma;…

read more
Get Clinical Tree app for offline access